Related references
Note: Only part of the references are listed.Fanconi anaemia and cancer: an intricate relationship
Grzegorz Nalepa et al.
NATURE REVIEWS CANCER (2018)
PARPi focus the spotlight on replication fork protection in cancer
Katharina Schlacher
NATURE CELL BIOLOGY (2017)
BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer
Maja Sedic et al.
CELL CYCLE (2016)
The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias
Maria Vittoria Verga Falzacappa et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen
Lucas B. Pontel et al.
MOLECULAR CELL (2015)
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Dagmar Walter et al.
NATURE (2015)
Global and disease-associated genetic variation in the human Fanconi anemia gene family
Kai J. Rogers et al.
HUMAN MOLECULAR GENETICS (2014)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML
Andrzej Rochowski et al.
PEDIATRIC BLOOD & CANCER (2012)
Cancer incidence in relatives of British Fanconi Anaemia patients
Marc Tischkowitz et al.
BMC CANCER (2008)
Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer
Marianne Berwick et al.
CANCER RESEARCH (2007)
A novel ubiquitin ligase is deficient in Fanconi anemia
AR Meetei et al.
NATURE GENETICS (2003)
Share Paper
